Overview
The Adviser is a New York-based private equity management firm that, together with its affiliates, provides
investment advisory services to pooled investment vehicles which are exempt from registration under the
Investment Company Act of 1940, as amended, which include Regal Healthcare Capital Partners, L.P.,
RHCP-II, L.P., RHCP-II QP, L.P., RHCP-III, L.P., and RHCP-III QP, L.P. (each a “Fund” and collectively,
the “Funds” or each a “Client” and collectively, the “Clients”). The Adviser has been in business since
2017 and its owners are David Kim, MD, Jon Santemma and Terry Wang.
The Adviser provides advisory services with respect to equity investments in private companies operating
in the healthcare sector. Interests in the Funds generally are privately offered to qualified limited partners
in the United States. The Funds make direct equity investments into small and medium-sized companies
that demonstrate a potential for longevity and growth. The Adviser’s investment advisory services consist
of identifying and evaluating investment opportunities and negotiating the terms of purchase and sale of
investments as well as providing day-to-day
managerial support services. Investments are made
predominantly in non-public companies, although investments in public companies are permitted in certain
instances. From time to time, the senior principals of the Adviser or other individuals chosen by the Adviser
may serve on portfolio companies’ respective boards of managers or otherwise act to influence control over
management of portfolio companies held by the Funds.
The Adviser tailors its advisory services to the individual needs of each of its Clients (not the individual
investors of the Clients) based on the specific characteristics of such Client, including but not limited to:
the stage in the investment period of each Client, and any other restrictions set forth in the private placement
memorandum, limited partnership agreement, investment advisory agreement and other governing
documents of the relevant Fund (collectively, “Governing Documents”).
The Adviser does not participate in wrap fee programs.
As of December 31, 2023, the Adviser had approximately $703,645,217 in regulatory assets under
management, all of which were managed on a discretionary basis.